Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
60.86(c) 61.62(c) 59.99(c) 60.9(c) 61.51 Last
10 227 657 7 610 418 13 095 613 9 192 264 6 254 123 Volume
+2.41% +1.25% -2.65% +1.52% +1.00% Change
More quotes
Financials ($)
Sales 2016 25 734 M
EBIT 2016 10 764 M
Net income 2016 6 749 M
Debt 2016 27 056 M
Yield 2016 3,75%
Sales 2017 28 282 M
EBIT 2017 12 176 M
Net income 2017 8 051 M
Debt 2017 25 054 M
Yield 2017 4,23%
P/E ratio 2016 15,94
P/E ratio 2017 12,65
EV / Sales2016 4,90x
EV / Sales2017 4,39x
Capitalization 98 969 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and... 
Sector
Pharmaceuticals
Calendar
01/11Ex-dividend day
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
02:02p ABBVIE : Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRY..
12/08 ABBVIE : Researchers from AbbVie Inc. Describe Findings in Osteoarthritis (Pharm..
12/08 ABBVIE : Findings from AbbVie Inc. in Affinity Labels Reported (2-Aryl-5-carboxy..
12/08 ABBVIE : Researchers from AbbVie Inc. Report Recent Findings in Psoriasis (Reduc..
12/07 ABBVIE : Northwestern, AbbVie team up on cancer research
12/06 ABBVIE : Hopkins, AbbVie ink five-year cancer research collaboration
12/06 ABBVIE : Northwestern, AbbVie team up on cancer research
12/05 ABBVIE : and Johns Hopkins to Collaborate on Cancer Research
12/05 ABBVIE : and Northwestern University's Lurie Cancer Center to collaborate on mul..
12/05 ABBVIE : Johns Hopkins to Collaborate on Cancer Research
More news
Sector news : Specialty & Advanced Pharmaceuticals
04:31pDJASTRAZENECA : FDA Accepts License Application for Durvalumab
02:05pDJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
News from SeekingAlpha
11:09a VALUATION DASHBOARD : Healthcare - Update
04:40a AbbVie Continues To Struggle But Almost Looks Attractive
12/08 New Oral Psoriasis Drug Tops Cellceutix Catalysts
12/08 WHY IS ABBVIE A STRONG BUY IN 2016? : Part 2
12/08 Roche's Venclyxto conditionally approved in Europe
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 69,9 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Azita Saleki-Gerhardt Senior Vice President-Operations
William J. Chase Chief Financial Officer & Executive Vice President
Michael E. Severino Chief Scientific Officer & Executive VP
Robert J. Alpern Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC2.80%98 969
MERCK KGAA2.65%12 712
KYOWA HAKKO KIRIN CO L..-20.26%7 648
JAZZ PHARMACEUTICALS P..-27.58%6 097
MALLINCKRODT PLC-29.85%5 542
ZHANGZHOU PIENTZEHUANG..1.57%4 078
More Results